Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 11, 2008
Grant Date -
Apr 21, 2005
app pub date -
Aug 24, 2004
filing date -
Aug 26, 2003
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrug of said compound, or pharmaceutically acceptable salts or solvates of said compound, or of said prodrug, said compound having the general structure shown in Formula 1: ##STR00001## useful in the treatment or prevention or amelioration of one or more symptoms of hepatitis C.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully